Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.
2.

Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.

Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M.

Oncoimmunology. 2015 May 7;4(8):e1026529. eCollection 2015 Aug.

3.

How do Australian podiatrists manage patients with diabetes? The Australian diabetic foot management survey.

Quinton TR, Lazzarini PA, Boyle FM, Russell AW, Armstrong DG.

J Foot Ankle Res. 2015 Apr 18;8:16. doi: 10.1186/s13047-015-0072-y. eCollection 2015.

4.

Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review.

Milne TE, Rogers JR, Kinnear EM, Martin HV, Lazzarini PA, Quinton TR, Boyle FM.

J Foot Ankle Res. 2013 Jul 30;6(1):30. doi: 10.1186/1757-1146-6-30.

5.

Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration.

Karkada M, Quinton T, Blackman R, Mansour M.

ISRN Oncol. 2013;2013:753427. doi: 10.1155/2013/753427. Epub 2013 Mar 7.

6.

The future of USP monographs for PET drugs.

Schwarz S, Norenberg J, Berridge M, Dragotakes S, Hung J, Link J, Mason NS, Mattmuller S, Nickel RA, Packard A, Paolino J, Petry N, Ponto J, Quinton TM, Seifert KL, Swanson D, Weiner RE, Zigler S.

J Nucl Med. 2013 Mar;54(3):472-5. doi: 10.2967/jnumed.112.115089. Epub 2012 Dec 21. No abstract available.

7.

A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery.

Karkada M, Weir GM, Quinton T, Fuentes-Ortega A, Mansour M.

Vaccine. 2010 Aug 31;28(38):6176-82. doi: 10.1016/j.vaccine.2010.07.025. Epub 2010 Jul 23. Erratum in: Vaccine. 2011 Jan 17;29(4):863.

PMID:
20656034
8.

A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.

Karkada M, Weir GM, Quinton T, Sammatur L, MacDonald LD, Grant A, Liwski R, Juskevicius R, Sinnathamby G, Philip R, Mansour M.

J Immunother. 2010 Apr;33(3):250-61. doi: 10.1097/CJI.0b013e3181c1f1e9.

PMID:
20445345
9.

A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States.

Schultz MK, Cessna JT, Anderson TL, Ponto JA, Petry N, Kowalsky RJ, Palmer MR, Beinlich UF, Baker W, Hinkle GH, Hung JC, Quinton T, Rice PA, Divgi C, Norenberg JP.

Appl Radiat Isot. 2008 Feb;66(2):252-60. Epub 2007 Sep 18.

PMID:
17933545
10.

Glycoprotein VI agonists have distinct dependences on the lipid raft environment.

Quinter PG, Dangelmaier CA, Quinton TM, Kunapuli SP, Daniel JL.

J Thromb Haemost. 2007 Feb;5(2):362-8. Epub 2006 Nov 10.

11.

Do heterotrimeric G proteins redistribute upon G protein-coupled receptor stimulation in platelets?

Kahner BN, Quinton TM, Langan S, Kunapuli SP.

Platelets. 2006 Sep;17(6):397-404.

PMID:
16973501
12.
13.

Genetic interactions between mediator and the late G1-specific transcription factor Swi6 in Saccharomyces cerevisiae.

Li L, Quinton T, Miles S, Breeden LL.

Genetics. 2005 Oct;171(2):477-88. Epub 2005 Jul 5.

14.
15.

Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets.

Quinton TM, Murugappan S, Kim S, Jin J, Kunapuli SP.

J Thromb Haemost. 2004 Jun;2(6):978-84.

16.

Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4.

Quinton TM, Kim S, Derian CK, Jin J, Kunapuli SP.

J Biol Chem. 2004 Apr 30;279(18):18434-9. Epub 2004 Feb 18.

17.

ADP receptors--targets for developing antithrombotic agents.

Kunapuli SP, Ding Z, Dorsam RT, Kim S, Murugappan S, Quinton TM.

Curr Pharm Des. 2003;9(28):2303-16. Review.

PMID:
14529392
18.

Platelet purinergic receptors.

Kunapuli SP, Dorsam RT, Kim S, Quinton TM.

Curr Opin Pharmacol. 2003 Apr;3(2):175-80. Review.

PMID:
12681240
19.

Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.

Hung JC, Augustine SC, Cheng KT, Green RL, Hopkins WM, Laven DL, Nelson BR, Petry NA, Ponto JA, Quinton TM, Swanson DP.

J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5):789-98.

PMID:
12269713
20.

Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.

Quinton TM, Kim S, Dangelmaier C, Dorsam RT, Jin J, Daniel JL, Kunapuli SP.

Biochem J. 2002 Dec 1;368(Pt 2):535-43.

21.

Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.

Kim S, Foster C, Lecchi A, Quinton TM, Prosser DM, Jin J, Cattaneo M, Kunapuli SP.

Blood. 2002 May 15;99(10):3629-36.

PMID:
11986217
22.
23.
24.

Human secretin (SCT): gene structure, chromosome location, and distribution of mRNA.

Whitmore TE, Holloway JL, Lofton-Day CE, Maurer MF, Chen L, Quinton TJ, Vincent JB, Scherer SW, Lok S.

Cytogenet Cell Genet. 2000;90(1-2):47-52.

PMID:
11060443
25.

CeReS-18 inhibits growth and induces apoptosis in human prostatic cancer cells.

Fattaey HK, Quinton TM, Zhao K, He F, Paulsen AQ, Johnson TC.

Prostate. 1999 Mar 1;38(4):285-95.

PMID:
10075008
26.

Influence of iodine-131 solution volume and storage time on in vitro dissolution.

Yu MD, Quinton T, Shaw SM.

J Nucl Med Technol. 1998 Dec;26(4):274-7.

PMID:
9884942
27.

Inhibition of cyclin D-cdk activity in cell cycle arrest of Swiss 3T3 cells by CeReS-18, a novel cell regulatory sialoglycopeptide.

Zhao K, Fattaey HK, Quinton TM, Johnson TC.

Exp Cell Res. 1998 Oct 10;244(1):295-301.

PMID:
9770372
28.

Multiple inositol 1,4,5-trisphosphate receptor isoforms are present in platelets.

Quinton TM, Dean WL.

Biochem Biophys Res Commun. 1996 Jul 25;224(3):740-6.

PMID:
8713116
29.
30.
31.
32.

Unusual features of integrated cDNAs generated by infection with genome-free retroviruses.

Levine KL, Steiner B, Johnson K, Aronoff R, Quinton TJ, Linial ML.

Mol Cell Biol. 1990 May;10(5):1891-900.

33.

The diffusion coefficient of oxygen in respiring kidney and tumour tissue.

Evans NT, Naylor PF, Quinton TH.

Respir Physiol. 1981 Mar;43(3):179-88.

PMID:
7280375
34.

Permeability and diffusion coefficient of oxygen in membranes for oxygen electrodes.

Evans NT, Quinton TH.

Respir Physiol. 1978 Oct;35(1):89-99.

PMID:
734252
35.

Complete heart block in pregnancy; report of two successful deliveries.

QUINTON TJ.

Can Med Assoc J. 1946 Dec;55(6):600. No abstract available.

Supplemental Content

Loading ...
Support Center